TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT03920254

TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“Stopped early due to company decision. Company decision based on interim analysis results in TD-1473-0157.”

The sponsor’s own words in the registry.

Life of this trial

20192020202120222023Registered2019-03-28Started2020-07-23Stopped2021-10-27Results posted2022-11-02

Vital statistics

Status
Terminated
Phase
Phase 2, Phase 3
Sponsor
Theravance Biopharma
Sponsor type
Industry
Conditions
Ulcerative Colitis (UC)
Interventions
TD-1473 Dose A; TD-1473 Dose B; TD-1473 Dose C
Participants
46
Sites
184
Countries
Australia, Bulgaria, Canada, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Japan, Poland and more

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.